Do you hold $CDXS, $MACI, or $FHTX ? Follow @reo_throb He discovers the most promising stocks every day. Last week I made $3,500 thanks to his recommendations! The fewer people who know, the greater the opportunity. There are no fees.

Which of the following stocks are you watching? $CDXS $MACI $FHTX Act now before everyone else reacts! Stay tuned for daily market updates and trading strategies. Dreaming of stable passive income? Click the link on my profile to explore upcoming hot stocks. 👇

Is there a hope for $FHTX?

The following stocks may rise: $CDXS, $MACI, $FHTX If you're not making $3,000 every two weeks, you should definitely follow this blogger, Get detailed explanation 👉@willRem01 His analysis and predictions are incredibly accurate; I've made a lot of money following his advice

Being sent to FHTX and the 1st CAV after the MCCC was a HUGE part of my decision to leave the Army. The Army wanted me to have some “heavy experience” since I was a “light PL.” It was truly like being on the JV team.

(1/2) SPHERA FUNDS MANAGEMENT LTD Q126 13F Changes: NEW: $CRIS, $CTMX, $IRON, $FHTX, $OLMA, $ORGO, $OVID, $RLAY, $UPB, $XENE, $ZBIO, $BHVN, $CLBT, $AMZN, $PANW Increased: $ABBV, $ACAD, $BCRX, $BBIO, $CLDX, $COGT, $CYBN, $CYTK, $IBIT, $MDGL, $MAZE, $MLYS, $NVO, $PALI, $PFE, $PRLD, $PMN, $RVMD, $XBI, $SNY, $STTK, $SKYE, $SLNO, $GPCR, $TEVA, $RARE, $VYGR, $CAMT, $MDWD, $NVMI, $TSEM, $WVE Decreased: $FOLD, $APLS, $ASND

(1/3) Deerfield Management Company, L.P. Q126 13F Changes: NEW: $BMRN, $DRUG, $DNTH, $GMAB, $PFE, $SNDX, $TYRA Increased: $BLTE, $BBNX, $BCRX, $PHGE, $IRON, $FHTX, $INSP, $LRMR, $LEGN, $MNPR, $PRAX, $TNGX, $UTHR, $XENE, $NAMS Decreased: $ARWR, $CPRX, $CNC, $EMBC, $NVST, $IDYA, $NBIX, $RVMD, $VERA CLOSED: $ABT, $ABBV, $ABEO, $ADUS, $AGLE, $ALGN, $ALHC, $ATEC, $AMPH, $ARVN, $ATRC, $AVNS, $BRBR, $BLFS, $BSX, $AZTA, $BFLY/WS, $CI, $CAH

SIO Capital Management Q1 2026 ➖ Unchanged (13): $ADGM, $BBOT, $BOLD, $ENTA, $FHTX, $HUMA, $KYMR, $NYXH, $RCKT, $SENS, $SVRA, $TELA, $TERN 📉 Decreased (15): $ALGS, $BHVN, $BMRN, $CELC, $CNTX, $DNTH, $ELTX (put), $HYPR, $NMTC, $OGN, $OVID, $PRQR, $SI, $SNY, $ZBH

Deerfield Management Q1 2026 🆕 New (12): $ARWR 0 01/15/32, $BMRN, $DNTH, $DRUG, $GMAB, $INDV, $MANE, $PFE, $SGP, $SNDX, $TYRA, $ZBIO 📈 Increased (14): $BBNX, $BCRX, $BLTE, $FHTX, $INSP, $IRON, $LEGN, $LRMR, $MNPR, $NAMS, $PRAX, $TNGX, $UTHR, $XENE

DAFNA Capital Q1 2026 📉 Decreased (28): $ADCT, $ALGN, $ANNX, $AQST, $ASND, $AXGN, $BHVN, $CGEN, $CYTK, $DAWN, $DXCM, $EWTX, $FHTX, $IBB, $IDYA, $IMTX, $IPSC, $KALV, $KPTI, $MDWD, $ORIC, $PROF, $RVMD, $SNDX, $SPRY, $VRCA, $XBI, $XENE ❌ Closed (4): $BWAY, $CATB, $CATX, $ERAS

BVF Inc Q1 2026 🆕 New (4): $ALKS, $AVR, $OKUR, $STRO 📈 Increased (10): $AVTX, $FHTX, $GLUE, $IMA, $IRON, $MIRM, $NKTR, $PVLA, $STOK, $TCRX

(1/2) DAFNA Capital Management LLC Q126 13F Changes: NEW: $CTMX, $FULC, $IBIO, $MAZE, $NMRA, $KIDS, $PLRX, $SCYX, $ZBIO, $NAMS Increased: $ARAY, $RCUS, $BCAX, $BCRX, $CMPS, $CYBN, $ENGN, $INSP, $INGN, $PODD, $LRMR, $LXEO, $MBX, $MPLT, $NKTR, $NGNE, $STOK, $GPCR, $RARE, $ALKS Decreased: $ALGN, $ALLO, $ANNX, $AQST, $ASND, $AXGN, $IPSC, $CYTK, $DAWN, $DXCM, $EWTX, $FHTX, $IDYA, $IBB, $KALV, $KPTI, $ORIC, $PROF, $RVMD, $XBI

BVF Partners, LP Q126 13F Changes: NEW: $AVR, $STRO, $ALKS Increased: $AVTX, $IRON, $FHTX, $IMA, $MIRM, $GLUE, $NKTR, $PVLA, $STOK, $TCRX Decreased: $ANNX, $FDMT, $IMCR, $KURA, $MLTX, $RVMD, $SEPN, $GPCR, $TYRA, $ZYME, $GHRS CLOSED: $ABVX, $AXSM, $PEPG, $RPTX

B Group, Inc Q126 13F Changes: NEW: $DRUG, $FHTX, $SLNO Increased: $ADMA, $AURA, $PALI, $SGHT, $GPCR, $ZLAB Decreased: $APGE, $REPL

سهم fhtx 4.80 هدف اول مقاومة اذا اخترقها بينفجر السهم الاهداف 4.52 4.80 5.54 6.00 بعدها يتحرر السهم وممكن يوصل 11 دولار لازم تصبر قبل يدخل المضارب

Added 80 new stock write-ups to the site (pt fin): @TheBioMAHunter (earnings) - $FHTX, $XENE, $JBIO, $ANNX, $BEAM, $BDTX, $INGN, $PTCT @WisemanCap - $NOW @guru_gems - $ZTS @Crowhurst68 - $KINS @Unclestocknotes (earnings) - $RMBS, $ONTO, $SMR @Muzzlebuster - $MELI (earnings)

Danette Daniels (FHTX) offered thoughtful lessons on the basics first, including potency (DC50), exposure (PK), and degradation rate. The last is not discussed as often and frequency lauded as fast is better than slow without qualifying it, but what does this mean exactly?

Biotech Stock News 4/22 @ Open (1️⃣ of 2) $INBX 28% Clinical Update on Ozekibart $MAZE 6% $150M Registered Offering $DTIL 5% PBGENE-HBV Presentation $SABS 4% Clinical data from SAB-142 trial $AMRX 4% To Acquire Kashiv BioScience $BLTE 4% Rolling Submission for Tinlarebant $TGTX 4% Data Presentations for BRIUMVI $OPK 3% Clinical Trial of Tetraspecific Antibody $CRBP 3% Abstracts Accepted for CRB-701 $FHTX 2% New Preclinical Data for FHD-909 $FENC 2% Acceptance of Abstracts at ASCO Mtg $IMRX 2% New survival data for Atebimetinib $ANIX 2% Ovarian Cancer CAR-T Tx Presentation $CORT 2% New data from ROSELLA Trial $NRXP 1% Positive FDA feedback on Ketamine $RFL 1% Patent Licensing Agreement w/ MIT $MRNA 1% Ph3 Study of mRNA Vaccine $NUVB 1% IBTROZI® Shows Durable Responses $CPIX 0% Opaganib enhances chemo efficacy $RHHBY 0% Fenebrutinib Reduces Relapses in RMS $JAZZ 0% Data on Ziihera and Zepzelca $ASRT 0% Update on Garda Therapeutics Tender $IPSEY 0% Ojemda® approved for pediatric glioma $AAPG 0% Present data from multiple trials See the image and comments for more details!

$RVMD's current market cap (~$29B) is greater than all of the listed Flagship Pioneering companies combined (MRNA, DNLI, SANA, FHTX, MCRB, OMGA, SYRS aggregate market cap~ $24.35B)

📣 Biotech Stock News 04/09 @ Open $FBRX 26% Pricing of $150M Offering $ZNTL 17% Azenosertib Monotherapy in Ovarian Cancer $IVVD 16% Progress on VMS063 for Measles $IFRX 11% New data for Izicopan $COYA 7% Correlation of Biomarkers and Outcomes $HCM 1% Data Presented at AACR Annual Meeting $ASMB 1% Positive Phase 1b Data for ABI-5366 $KURA 1% Darlifarnib Plus Cabozantinib Data Presentation $NKGN 0% Present Troculeucel data in Alzheimer's $CCCC 0% New Collaboration for Degrader-Antibody Conjugates $KYTX 0% New Data Across Neuroimmunology Franchise $JAZZ 0% Research on Epidiolex and Xywav $KYMR 0% Option Exercise for KT-200 License $BMY 0% Collaboration for Next-Generation T-cell Engagers $AMRX 0% Launches Bimatoprost Ophthalmic Solution $GILD 0% Strategic Collaboration to Advance Oncology $LLY 0% Orforglipron now available in U.S. $SNY -1% Market authorization for Nuvaxovid® $VNDA -1% Initiation of The Thetis Study $ASRT -2% Agreement to be Acquired $MGNX -4% FDA Lifts Clinical Hold on LINNET $NTRA -4% 30% Ongoing Royalty for MRD Patents $FHTX -4% New Preclinical Data for FHD-909 $ANVS -22% $10 Million Underwritten Offering See image below for details. 👇